<i>In-Silico</i> Identification of Anticancer Compounds; Ligand-Based Pharmacophore Approach against EGFR Involved in Breast Cancer

Journals Menu

Follow SCIRP

ISSN Print: 2168-1589
ISSN Online: 2168-1597
www.scirp.org/journal/abcr
E-mail: abcr@scirp.org

Citations h5-index & Ranking*

"In-Silico Identification of Anticancer Compounds; Ligand-Based Pharmacophore Approach against EGFR Involved in Breast Cancer"
written by Irum Khalid, Tassadaq Hussain Jafar, Ahsanullah Unar, Rabia Rasool, Ayesha Sahar, Hamid Rashid,
published by Advances in Breast Cancer Research, Vol.10 No.3, 2021

has been cited by the following article(s):

[1]	Novel and Latest Computational and Development of Anticancer Cancer
	Onco Therapeutics, 2022

[2]	Novel and latest computational routes for design and development of anticancer drugs for colon cancer

[1]	Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship Anti-Cancer Agents in Medicinal Chemistry, 2023 DOI:10.2174/1871520623666230227153449

[2]	Novel and Latest Computational and Development of Anticancer Cancer Onco Therapeutics, 2022 DOI:10.1615/OncoTherap.2022044866

[3]	Novel and Latest Computational and Development of Anticancer Cancer Onco Therapeutics, 2022 DOI:10.1615/OncoTherap.2022044866

Follow SCIRP